Literature DB >> 350269

Mechanisms of selective inhibition of 3' to 5' exonuclease activity of Escherichia coli DNA polymerase I by nucleoside 5'-monophosphates.

B G Que, K M Downey, A G So.   

Abstract

The 3' to 5' exonuclease activity of Escherichia coli DNA polymerase I can be selectively inhibited by nucleoside 5'-monophosphates, wherease the DNA polymerase activity is not inhibited. The results of kinetic studies show that nucleotides containing a free 3'-hydroxy group and a 5'-phosphoryl group are competitive inhibitors of the 3' to 5' exonuclease. Previous studies by Huberman and Kornberg [Huberman, J., and Kornberg, A. (1970), J. Biol. Chem. 245, 5326] have demonstrated a binding site for nucleoside 5'-monophosphates on DNA polymerase I. The Kdissoc values for nucleoside 5'-monophosphates determined in that study are comparable to the Ki values determined in the present study, suggesting that the specific binding site for nucleoside 5'-monophosphates represents the inhibitor site of the 3' to 5' exonuclease activity. We propose that (1) the binding site for nucleoside 5'-monophosphates on DNA polymerase I may represent the product site of the 3' to 5' exonuclease activity. (2) the primer terminus site for the 3' to 5' exonuclease activity is distinct from the primer terminus site for the polymerase activity, and (3) nucleoside 5'-monophosphates bind at the primer terminus site for the 3' to 5' exonuclease activity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 350269     DOI: 10.1021/bi00602a004

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Exonucleolytic proofreading of leading and lagging strand DNA replication errors.

Authors:  J D Roberts; D C Thomas; T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

Review 2.  Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription.

Authors:  E J Arts; M A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

3.  Exonucleolytic proofreading by calf thymus DNA polymerase delta.

Authors:  T A Kunkel; R D Sabatino; R A Bambara
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

4.  Polymerization activity of an alpha-like DNA polymerase requires a conserved 3'-5' exonuclease active site.

Authors:  J S Gibbs; K Weisshart; P Digard; A deBruynKops; D M Knipe; D M Coen
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

5.  Molecular mechanisms of manganese mutagenesis.

Authors:  W S El-Deiry; K M Downey; A G So
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

6.  Identification of a 3'-->5' exonuclease activity associated with human RNA polymerase II.

Authors:  D Wang; D K Hawley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

7.  Selective inactivation of the 3' to 5' exonuclease activity of Escherichia coli DNA polymerase I by heat.

Authors:  P J Lecomte; O P Doubleday
Journal:  Nucleic Acids Res       Date:  1983-11-11       Impact factor: 16.971

8.  In vitro DNA replication implicates O2-ethyldeoxythymidine in transversion mutagenesis by ethylating agents.

Authors:  O S Bhanot; P C Grevatt; J M Donahue; C N Gabrielides; J J Solomon
Journal:  Nucleic Acids Res       Date:  1992-02-11       Impact factor: 16.971

9.  A genetic screen pinpoints ribonucleotide reductase residues that sustain dNTP homeostasis and specifies a highly mutagenic type of dNTP imbalance.

Authors:  Tobias T Schmidt; Sushma Sharma; Gloria X Reyes; Kerstin Gries; Maike Gross; Boyu Zhao; Jui-Hung Yuan; Rebecca Wade; Andrei Chabes; Hans Hombauer
Journal:  Nucleic Acids Res       Date:  2019-01-10       Impact factor: 16.971

10.  The 3'-5' exonuclease of DNA polymerase I of Escherichia coli: contribution of each amino acid at the active site to the reaction.

Authors:  V Derbyshire; N D Grindley; C M Joyce
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.